SNN
Smith & Nephew plc NYSE Listed Nov 16, 1999$30.08
+0.03%
vs $30.07
Mkt Cap $13.1B
52w Low $28.58
14.8% of range
52w High $38.70
50d MA $31.11
200d MA $33.62
P/E (TTM)
20.9x
EV/EBITDA
9.9x
P/B
2.5x
Debt/Equity
0.6x
ROE
—
P/FCF
15.4x
RSI (14)
54.20
ATR (14)
$0.49
Beta
0.74
50d MA
$31.11
200d MA
$33.62
Avg Volume
1.2M
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Building 5 · Watford WD18 8YE · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 1.16 | 1.18 | +1.7% | 35.76 | +1.3% | +2.8% | -1.1% | -4.2% | -1.5% | -0.7% | — |
| Aug 5, 2025 | AMC | 0.86 | 0.67 | -21.7% | 35.48 | +0.4% | +0.1% | +1.6% | +0.2% | -0.5% | +0.8% | — |
| Feb 25, 2025 | AMC | 0.92 | 0.23 | -75.5% | 28.11 | +2.7% | +2.9% | +0.2% | -0.1% | +2.4% | +1.2% | — |
| Oct 31, 2024 | AMC | 0.79 | 0.24 | -68.8% | 25.09 | +2.2% | +0.6% | +0.2% | +1.1% | -4.2% | +0.9% | — |
| Feb 27, 2024 | AMC | 0.97 | 0.05 | -94.6% | 27.96 | -3.4% | -5.5% | +0.3% | -0.3% | +0.3% | +0.5% | — |
| Aug 3, 2023 | AMC | 0.73 | 0.10 | -86.5% | 28.48 | +0.5% | +0.4% | -0.1% | -1.1% | +0.5% | -0.3% | — |
| Feb 28, 2023 | AMC | 0.73 | 0.03 | -96.4% | 28.57 | +1.5% | +0.4% | +0.3% | +2.1% | -1.6% | -0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4 | Kepler | Downgrade | Buy → Hold | — | $29.93 | $30.30 | +1.2% | +3.1% | -0.8% | -0.9% | +3.2% | -1.3% |
| Mar 5 | Canaccord Genuity | Maintains | Hold → Hold | — | $36.36 | $34.87 | -4.1% | -4.2% | -1.5% | -0.7% | -3.0% | +0.9% |
| Nov 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $33.35 | $33.10 | -0.7% | -0.2% | +0.6% | -1.5% | -0.8% | -0.4% |
| Oct 14 | Bernstein | Downgrade | Outperform → Market Perform | — | $35.21 | $34.74 | -1.3% | +0.1% | +0.3% | +1.2% | +1.5% | -0.0% |
| Aug 18 | Canaccord Genuity | Maintains | Hold → Hold | — | $36.20 | $36.64 | +1.2% | +0.2% | +1.6% | +1.4% | -1.2% | +1.4% |
| May 1 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.02 | $28.29 | +1.0% | +0.7% | +1.4% | -0.9% | +0.2% | -0.4% |
| Mar 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.57 | $28.75 | +0.6% | +1.6% | -0.9% | -1.3% | +0.2% | -1.2% |
| Mar 12 | UBS | Downgrade | Buy → Neutral | — | $29.84 | $28.81 | -3.5% | -3.4% | -2.2% | +1.3% | +1.6% | -0.9% |
| Feb 26 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.11 | $28.86 | +2.7% | +2.9% | +0.2% | -0.1% | +2.4% | +1.2% |
| Jun 5 | UBS | Upgrade | Neutral → Buy | — | $25.51 | $26.18 | +2.6% | +2.9% | +0.8% | -0.5% | -0.7% | -1.5% |
| Oct 4 | Bernstein | Maintains | Outperform → Outperform | — | $23.75 | $23.89 | +0.6% | +0.0% | -0.9% | +0.7% | +0.3% | +0.8% |
| Mar 4 | Redburn Partners | Upgrade | Sell → Neutral | — | $33.95 | $32.79 | -3.4% | -2.1% | -4.5% | -0.6% | +1.1% | -3.1% |
| Apr 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $43.18 | $43.25 | +0.2% | -0.0% | +0.8% | -2.9% | +1.8% | +1.4% |
| Dec 18 | Bernstein | Upgrade | Market Perform → Outperform | — | $41.86 | $41.74 | -0.3% | -0.2% | -0.5% | +0.5% | +0.6% | +0.1% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $35.61 | $35.30 | -0.9% | -1.5% | +0.1% | +3.2% | +2.1% | -0.1% |
| May 7 | CFRA | Maintains | Hold → Hold | — | $40.04 | $40.79 | +1.9% | +1.7% | -0.2% | -0.8% | -0.5% | -4.8% |
| Feb 21 | CFRA | Maintains | Hold → Hold | — | $51.64 | $50.48 | -2.2% | -2.3% | -3.0% | -2.8% | -0.1% | -2.6% |
| Nov 12 | Bernstein | Maintains | Outperform → Outperform | — | $42.31 | $42.26 | -0.1% | -0.1% | +1.9% | -0.4% | +0.7% | +0.6% |
| Apr 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $38.29 | $38.04 | -0.7% | +1.0% | +0.8% | +0.0% | +0.2% | -0.7% |
| Aug 8 | UBS | Downgrade | Buy → Neutral | — | $35.66 | $35.56 | -0.3% | -0.4% | +0.4% | -1.3% | +0.3% | +0.3% |
| May 4 | Deutsche Bank | Downgrade | Hold → Sell | — | $36.00 | $35.62 | -1.1% | -0.4% | -0.1% | -0.6% | +0.3% | +0.9% |
| Mar 26 | HSBC | Upgrade | Hold → Buy | — | $37.01 | $37.80 | +2.1% | +2.6% | +0.2% | +1.0% | -0.8% | -1.1% |
| Dec 11 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $36.13 | $35.50 | -1.7% | -1.8% | +0.2% | -0.4% | -0.7% | -1.1% |
| Oct 11 | Canaccord Genuity | Maintains | Buy → Buy | — | $37.81 | $37.50 | -0.8% | -0.6% | +1.8% | +0.6% | -1.3% | +0.2% |
| Oct 6 | Berenberg | Downgrade | Buy → Hold | — | $32.44 | $31.20 | -3.8% | -3.2% | -0.1% | -0.3% | -2.0% | -1.2% |
| Aug 10 | Barclays | Downgrade | Overweight → Equal Weight | — | $33.62 | $33.19 | -1.3% | -1.0% | +1.3% | -0.1% | +0.4% | -0.1% |
| May 9 | Jefferies | Upgrade | Hold → Buy | — | $33.41 | $33.84 | +1.3% | +1.9% | -0.2% | -0.3% | +0.2% | -0.7% |
| Feb 26 | Cantor Fitzgerald | Maintains | Hold → Hold | — | $33.24 | $32.93 | -0.9% | -1.3% | -0.5% | +2.1% | -0.0% | -0.9% |
| Feb 11 | UBS | Downgrade | Buy → Neutral | — | $31.48 | $30.93 | -1.7% | -3.0% | +2.0% | +2.6% | +3.0% | +0.3% |
| Jan 19 | Deutsche Bank | Downgrade | Buy → Hold | — | $31.85 | $31.90 | +0.2% | -1.0% | -0.2% | +0.4% | +4.0% | -1.4% |
| Nov 4 | Sterne Agee CRT | Maintains | Neutral → Neutral | — | $34.27 | $34.57 | +0.9% | -0.5% | -1.1% | +0.1% | -1.5% | -0.2% |
| Oct 30 | Beaufort Securities | Maintains | Hold → Hold | — | $33.57 | $33.84 | +0.8% | +1.6% | +0.8% | -0.3% | -0.5% | -1.1% |
| Jul 9 | Berenberg | Maintains | Buy → Buy | — | $33.24 | $34.14 | +2.7% | +2.5% | +2.4% | +0.7% | +1.4% | +0.0% |
| Jun 23 | UBS | Upgrade | Neutral → Buy | — | $34.40 | $35.00 | +1.7% | +1.5% | -0.3% | +0.2% | -0.7% | -2.4% |
| Mar 23 | Goldman Sachs | Upgrade | Neutral → Buy | — | $34.27 | $34.59 | +0.9% | +0.9% | +0.4% | -1.3% | +0.0% | -0.0% |
| Nov 28 | Morgan Stanley | Maintains | Underweight → Underweight | — | $35.76 | $34.64 | -3.1% | -2.9% | -0.5% | -0.1% | +1.3% | -0.8% |
| May 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.29 | $31.02 | -0.9% | -0.9% | +0.1% | +2.5% | +1.4% | -0.8% |
| Apr 3 | Numis Securities | Downgrade | Buy → Hold | — | $30.63 | $30.48 | -0.5% | -0.6% | -0.0% | -0.8% | -0.3% | +1.3% |
| Mar 28 | Investec | Maintains | Buy → Buy | — | $30.10 | $30.89 | +2.6% | +2.1% | -0.4% | +0.7% | -0.5% | -0.6% |
| Feb 12 | Deutsche Bank | Upgrade | Hold → Buy | — | $30.74 | $30.84 | +0.3% | +0.8% | +0.9% | +1.1% | +0.3% | +0.1% |
| Jan 27 | UBS | Upgrade | Neutral → Buy | — | $29.04 | $29.57 | +1.8% | +1.1% | +0.5% | -2.1% | +1.5% | -1.5% |
| Dec 19 | BofA Securities | Upgrade | Neutral → Buy | — | $27.88 | $28.08 | +0.7% | +0.5% | -0.1% | +1.6% | +0.2% | +0.8% |
| Dec 2 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $26.75 | $26.77 | +0.1% | +0.5% | +1.2% | +0.3% | +0.7% | +1.9% |
| Nov 1 | Investec | Upgrade | Hold → Buy | — | $25.68 | $25.64 | -0.2% | +0.3% | +0.3% | +0.2% | +0.5% | -0.9% |
| Aug 13 | Citigroup | Downgrade | Buy → Neutral | — | $24.32 | $24.29 | -0.1% | +1.0% | +0.2% | -1.1% | +0.0% | +0.5% |
| Jul 24 | Investec | Downgrade | Buy → Hold | — | $24.25 | $24.39 | +0.6% | -0.0% | -0.1% | -0.3% | -0.6% | -0.2% |
| Dec 10 | Investec | Upgrade | Hold → Buy | — | $21.38 | $21.58 | +0.9% | +1.6% | +0.6% | +0.1% | -1.3% | +0.0% |
| Oct 2 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $22.29 | $22.16 | -0.6% | -0.4% | -0.4% | +0.4% | -1.2% | -0.6% |
| Sep 10 | Citigroup | Upgrade | Neutral → Buy | — | $21.76 | $21.73 | -0.1% | -1.0% | +1.2% | +0.7% | +2.0% | -0.1% |
| Aug 13 | Piper Sandler | Maintains | Neutral → Neutral | — | $20.96 | $20.89 | -0.3% | -0.7% | +0.5% | +1.0% | -0.1% | -1.3% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 3,578,940 | $117M | Reduced | Dec 2025 |
| 2 | River Road Asset Management, Llc | 3,241,750 | $103M | Added | Mar 2026 |
| 3 | Bank Of Montreal /can/ | 2,243,019 | $71M | Reduced | Mar 2026 |
| 4 | Bank Of America Corp /de/ | 1,240,440 | $39M | Added | Mar 2026 |
| 5 | Causeway Capital Management Llc | 953,146 | $30M | Added | Mar 2026 |
| 6 | D.e. Shaw & Co | 911,727 | $29M | Added | Mar 2026 |
| 7 | Raymond James Financial Inc | 888,245 | $28M | Added | Mar 2026 |
| 8 | Northern Trust Corp | 814,945 | $26M | Added | Mar 2026 |
| 9 | Bnp Paribas Financial Markets | 738,922 | $23M | Reduced | Mar 2026 |
| 10 | Fmr Llc | 605,513 | $19M | Added | Mar 2026 |
| 11 | Wells Fargo & Company/mn | 517,651 | $16M | New | Mar 2026 |
| 12 | Deprince Race & Zollo Inc | 360,049 | $11M | Reduced | Mar 2026 |
| 13 | Arrowstreet Capital, Limited Partnership | 343,482 | $11M | Reduced | Mar 2026 |
| 14 | Royal Bank Of Canada | 337,118 | $11M | Added | Mar 2026 |
| 15 | Ubs Group Ag | 326,304 | $10M | Added | Mar 2026 |
| 16 | Clark Estates Inc/ny | 300,000 | $10M | Reduced | Dec 2025 |
| 17 | Abc Arbitrage Sa | 290,681 | $9M | Reduced | Mar 2026 |
| 18 | Quantinno Capital Management Lp | 278,224 | $9M | Added | Mar 2026 |
| 19 | Bridgewater Associates, Lp | 275,461 | $9M | Reduced | Mar 2026 |
| 20 | Lorne Steinberg Wealth Management Inc. | 266,380 | $8M | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$13.13B
Enterprise Value
$15.60B
P/E (TTM)
20.89x
Forward P/E
13.46x
PEG Ratio
0.41x
P/B
2.47x
P/S
2.12x
P/FCF
15.37x
EV/EBITDA
9.88x
Shares Out
436.5M
Financials (TTM)
Revenue
$6.18B
Net Income
$626.5M
EBITDA
$1.58B
Free Cash Flow
$854.0M
Op Cash Flow
$1.29B
EPS Basic
$1.46
EPS Diluted
$1.44
EPS Forward
$2.24
Gross Margin
68.0%
Op Margin
16.3%
Net Margin
10.1%
Balance Sheet
Total Assets
$10.46B
Total Liab.
$5.17B
Total Equity
$5.29B
Cash
$557.0M
LT Debt
$3.03B
Book Value/Sh
$12.20
Debt/Equity
0.63x
Current Ratio
2.57
Quick Ratio
1.25
Returns & Growth
ROE
—
ROA
—
ROIC
8.9%
Rev Growth YoY
+6.3%
EPS Growth YoY
+55.3%
Price Returns
2W
-0.1%
1M
-4.0%
3M
-19.5%
6M
-10.8%
12M
+2.5%
Technicals
52W High
$38.70
52W Low
$28.58
50d MA
$31.11
200d MA
$33.62
RSI (14)
54.20
ATR (14)
$0.49
Beta
0.74
Avg Volume
1.2M
Dividends
Div Rate
$0.76
Div Yield
2.5%
Frequency
2
Ex-Div Date
Mar 27, 2026
Analyst Price Targets
Consensus
$32.00
High
$32.00
Low
$32.00
Median
$32.00
Data updated apr 27, 2026 2:11am
· Source: financialmodelingprep.com